We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Carnival (CCL) Expands Cruise Fleet With 1st LNG-Based Ship
Read MoreHide Full Article
Carnival Corporation & Plc (CCL - Free Report) recently announced that it has taken delivery of its new ship, Mardi Gras, at the Meyer Turku Shipyard in Finland. The 180,000-gross-ton unit will be the first ship to be powered by liquefied natural gas (LNG) and feature an on-board roller coaster.
The 5,200-guest capacity ship comprises more than 2,600 staterooms and 180 suites across 11 categories. It also comes with dining and entertainment venues spread across six distinctive zones.
With respect to this, Christine Duffy, president of Carnival Cruise Line, stated, "We have been working tirelessly this year to get to this exciting day to take delivery of this beautiful ship, and the team at Meyer Turku has been an outstanding partner throughout this process."
Going forward, the company remains optimistic about welcoming guests as the ship is scheduled to arrive in North America later this month. The ship will operate on a seven-day Caribbean itinerary, with its inaugural voyage scheduled on Apr 24, 2021.
Price Performance
Shares of Carnival have gained 49% in the past three months compared with the industry's 31.8% growth. The company has been witnessing ticket price improvements in both North American and EAA brands, with robust ticket price growth in its Caribbean deployment. Also, it remains optimistic about its innovations featuring Ocean Medallion, PlayOcean and OceanView. Earnings estimates for 2021 have moved up over the past 30 days, depicting analysts’ optimism regarding the stock’s growth potential.
However, coronavirus-related woes persist. Owing to the uncertainty of the crisis, the company is unable to predict when the entire fleet will return to normal operations.
Carnival — which shares space with Norwegian Cruise Line Holdings Ltd. (NCLH - Free Report) and Royal Caribbean Cruises Ltd. (RCL - Free Report) — has a Zacks Rank #3 (Hold) at present.
YETI Holdings has a three-five year earnings per share growth rate of 18.3%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
Image: Bigstock
Carnival (CCL) Expands Cruise Fleet With 1st LNG-Based Ship
Carnival Corporation & Plc (CCL - Free Report) recently announced that it has taken delivery of its new ship, Mardi Gras, at the Meyer Turku Shipyard in Finland. The 180,000-gross-ton unit will be the first ship to be powered by liquefied natural gas (LNG) and feature an on-board roller coaster.
The 5,200-guest capacity ship comprises more than 2,600 staterooms and 180 suites across 11 categories. It also comes with dining and entertainment venues spread across six distinctive zones.
With respect to this, Christine Duffy, president of Carnival Cruise Line, stated, "We have been working tirelessly this year to get to this exciting day to take delivery of this beautiful ship, and the team at Meyer Turku has been an outstanding partner throughout this process."
Going forward, the company remains optimistic about welcoming guests as the ship is scheduled to arrive in North America later this month. The ship will operate on a seven-day Caribbean itinerary, with its inaugural voyage scheduled on Apr 24, 2021.
Price Performance
Shares of Carnival have gained 49% in the past three months compared with the industry's 31.8% growth. The company has been witnessing ticket price improvements in both North American and EAA brands, with robust ticket price growth in its Caribbean deployment. Also, it remains optimistic about its innovations featuring Ocean Medallion, PlayOcean and OceanView. Earnings estimates for 2021 have moved up over the past 30 days, depicting analysts’ optimism regarding the stock’s growth potential.
However, coronavirus-related woes persist. Owing to the uncertainty of the crisis, the company is unable to predict when the entire fleet will return to normal operations.
Carnival — which shares space with Norwegian Cruise Line Holdings Ltd. (NCLH - Free Report) and Royal Caribbean Cruises Ltd. (RCL - Free Report) — has a Zacks Rank #3 (Hold) at present.
Key Pick
A better-ranked stock in the Zacks Consumer Discretionary space is YETI Holdings, Inc. (YETI - Free Report) , which carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
YETI Holdings has a three-five year earnings per share growth rate of 18.3%.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>